- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06011720
Transitions of Care for Stroke Patients
May 23, 2026 updated by: Deviyani Mehta, MD
Collaborative Study to Reduce Length of Stay and Improve Transitions of Care for Stroke Patients at Robert Wood Johnson University Hospital & JFK Johnson Rehabilitation Institute
For stroke patients, early initiation of therapy typically yields the best functional outcomes.
Rehabilitation of stroke patients immediately after hospitalization minimizes deleterious effects of immobility and facilitates restoration of function.
The investigators are testing if coordinated efforts between the medical and rehabilitation disciplines may improve stroke patient's functional recovery and subsequent follow-ups after discharge.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Stroke is the fifth leading cause of mortality, claiming the lives of 133,000 individuals in the United States annually.
Approximately one-quarter of the 795,000 annual strokes are recurrent.
It is estimated that up to 80% of all strokes can be prevented.
Forty percent of stroke survivors sustain moderate functional impairments and 15% to 30% sustain severe disability.
Approximately 25% of adult stroke patients are readmitted to the hospital within six to twelve months of their preliminary stroke.
Identifying and implementing effective medical and rehabilitation interventions is critical in providing care to stroke patients.
The goal is to provide optimal, cost-effective care that: 1) prevents secondary medical complications, readmissions, and recurrent disease, and 2) maximizes patient function physically, cognitively, and socially.
JFK Johnson Rehabilitation Institute (JRI) proposes a collaborative study with Robert Wood Johnson University Hospital (RWJUH) that addresses this issue while proving beneficial to stroke patients at both institutions.
Streamlining the physiatry consult process will improve access to rehabilitation medicine specialty care for acute patients at RWJUH and help facilitate the transfer of stroke patients to the next most appropriate level of care.
Study Type
Observational
Enrollment (Estimated)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
New Brunswick, New Jersey, United States, 08901
- Rutgers-RWJMS Department of Neurology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Stroke patients hospitalized within Robert Wood Johnson University Hospital system for Ischemic Stroke or Intracerebral Hemorrhage within the two time frames, July 1st 2015 - June 30th 2017 and January 1st 2018 - December 31st 2019.
Description
Inclusion Criteria:
- Stroke patients hospitalized within Robert Wood Johnson University Hospital system for Ischemic Stroke or Intracerebral Hemorrhage.
Exclusion Criteria:
- Those not in the Robert Wood Johnson University Hospital system.
- Those with a Subarachnoid Hemorrhage or Transient Ischemic Attack (< 24 hours).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Stroke Patients July 1st 2015 - June 30th 2017
Stroke patients that have undergone hospitalization within the time frame July 1st 2015 - June 30th 2017 to be used as a baseline.
|
|
|
Stroke Patients January 1st 2018 - December 31st 2019
Stroke patients that have undergone hospitalization and undergone improvements to transition of care within the time frame January 1st 2018 - December 31st 2019.
|
Evaluation of how early physiatry consultation after acute stroke affects length of stay and resulting outcomes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of stay (in hours and days).
Time Frame: Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
We standardized the placement of early physiatry consults during patient admission.
We will determine the effect this has on overall acute care length of stay in ischemic and hemorrhagic stroke patients.
|
Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rehospitalization rate.
Time Frame: Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
We standardized placement of early physiatry consults during patient admission, and will determine the effect this has on acute care readmission rates (for the same stroke related problems).
This will be measured as absolute value and mean number of readmissions in the preintervention group and the post-intervention group, as well as percent of patients with readmissions in each group.
|
Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
|
Functional independence
Time Frame: Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
We standardized placement of early physiatry consults during patient admission, and will determine any differences in long term functional independence by means of a 90 day modified Rankin Scale (mRS) - a standard rater driven scale that characterizes patient's level of independence on a scale of 0-6 (0 being without symptoms and 6 being deceased).
|
Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
|
Stroke clinic outpatient follow-up.
Time Frame: Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
We standardized placement of early physiatry consulted during patient admission, and will determine the rate of stroke clinic outpatient follow-up, as measured by absolute number of patients who follow-up at least once.
We will further determine the relative percentage of patients who follow-up in stroke clinic for the preintervention and postintervention group.
|
Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
|
Pre-specified subanalyses for effect on primary outcome measures.
Time Frame: Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
We will assess the independent effects of multiple variables on length of stay, functional independence and stroke clinic outpatient follow-up.
The pre-specified variables include: presence/number/nature of medical comorbidities, stroke type (i.e.
ischemic vs. hemorrhagic), insurance type (i.e.
private insurance, Medicaid, managed Medicaid, etc.), severity of stroke on admission (measured by NIHSS or ICH score), prior antithrombotic use.
|
Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
|
Pre-specified subanalyses for effect on functional independence.
Time Frame: Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
We will assess the independent effects of multiple variables on functional independence (mRS).
The variables include: time between discharge and rehab admittance (days and hours), rehab length of stay (days and hours), and presence of outpatient follow-up.
|
Data from 1/1/2018-12/31/2019, collected under updated standard of care compared to baseline data from 7/1/2015-6/30/2017.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Deviyani Mehta, MD, Rutgers, The State University of New Jersey
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2019
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2027
Study Registration Dates
First Submitted
February 18, 2022
First Submitted That Met QC Criteria
August 23, 2023
First Posted (Actual)
August 25, 2023
Study Record Updates
Last Update Posted (Actual)
May 28, 2026
Last Update Submitted That Met QC Criteria
May 23, 2026
Last Verified
December 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Pathologic Processes
- Hemorrhage
- Brain Ischemia
- Intracranial Hemorrhages
- Pathological Conditions, Signs and Symptoms
- Ischemic Stroke
- Stroke
- Ischemic Attack, Transient
- Cerebral Hemorrhage
Other Study ID Numbers
- Pro2019000095
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Improved transition of care.
-
Massachusetts General HospitalCompleted
-
BaycrestOntario Ministry of Health and Long Term CareTerminatedDementia | BPSDCanada
-
Karolinska InstitutetForteCompletedStroke | Transient Ischemic AttackSweden
-
Washington University School of MedicineTerminatedMultiple MyelomaUnited States
-
McMaster UniversityCompletedInflammatory Bowel Diseases | Juvenile Idiopathic ArthritisCanada
-
University of North Carolina, Chapel HillNational Institutes of Health (NIH); Fogarty International Center of the National...RecruitingHIV | Noncommunicable DiseasesMalawi
-
Tabula Rasa HealthCareTerminated
-
Trillium Health PartnersCentre for Aging and Brain Health InnovationUnknownCommunication | Care TransitionCanada
-
IRCCS Policlinico S. DonatoRecruitingCongenital Heart DiseaseItaly
-
Wake Forest University Health SciencesThe Duke EndowmentCompletedMental Health IssueUnited States